More Post from the Author
- Alesha Dixon Hosts Season 2 of DXB Unheard, Uncovering the Real Stories of the Remarkable Individuals Who Call Dubai Home
- Texas Sports Academy Online Launches Statewide to Give Texas Student-Athletes a Two-Hour Academic Model and All-Afternoon Training, Fully Covered by Texas School Choice Vouchers
- Quinnipiac University Selects Unimarket to Consolidate and Modernize Source-to-Pay Operations
- Gem City Shining TV Series Spotlights Dayton Real Estate and Lifestyle on REAL Shows Network
- Phemex voltooit volledige integratie van het tokenized aandelenaanbod van Ondo Finance
Indivior Statement RE: Delayed FDA Approval of SUBLOCADE Label Changes
Published on Wed 12 Feb 2025 8:07:04 UTC
RICHMOND, Va., Feb. 12, 2025 /PRNewswire/ --Indivior PLC (Nasdaq/LSE: INDV)provides the following update regarding its PDUFA action date for label changes (rapid initiation protocol and alternative injection sites) for SUBLOCADE (buprenorphine extended-release) Injection, which was scheduled for February 7, 2025:
Yesterday, February 11th, the FDA informed Indivior that, following acceptance of the proposed label for SUBLOCADE, there were no outstanding items to address, but that final review of the SUBLOCADE label changes has been delayed.
Indivior will provide further updates on the status of the approval of the proposed SUBLOCADE label changes as appropriate.
SOURCE Indivior PLC
More Post from the Author
- Alesha Dixon Hosts Season 2 of DXB Unheard, Uncovering the Real Stories of the Remarkable Individuals Who Call Dubai Home
- Texas Sports Academy Online Launches Statewide to Give Texas Student-Athletes a Two-Hour Academic Model and All-Afternoon Training, Fully Covered by Texas School Choice Vouchers
- Quinnipiac University Selects Unimarket to Consolidate and Modernize Source-to-Pay Operations
- Gem City Shining TV Series Spotlights Dayton Real Estate and Lifestyle on REAL Shows Network
- Phemex voltooit volledige integratie van het tokenized aandelenaanbod van Ondo Finance